Psychosis - Articles - Page 4 | CARLAT PUBLISHING

EXPERT Q&A

Cognitive Rehabilitation for Youth With Psychotic Disorders

May 7, 2020

Ian S. Ramsay, PhD
Assistant Professor in the Department of Psychiatry at University of Minnesota. Dr. Ramsay has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Psychotic disorders in children and adolescents include a range of neuropsychiatric problems related to the multitude of underlying neurophysiological differences and the problems created by these differences. Chief among these are cognitive impacts. This interview helps outline and give guidance for managing these cognitive problems related to both psychosis and to the medication treatments that themselves can add to these problems.

A Potentially Lethal Side Effect You Probably Never Heard Of

May 7, 2020

Chris Aiken, MD.

Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The FDA recently raised alerts about a potentially fatal side effect on clozapine that’s causing more fatalities than neutropenia. It’s constipation, and the problem extends to a few other psychotropics as well. In this article, a three step, evidence-based algorithm for managing it.

How to Choose an Antipsychotic in Schizophrenia

March 30, 2020

Rehan Aziz, MD.

Rehan Aziz, MD. Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Atypical antipsychotics are more alike than different, but a few stand out for tolerability, while others may have an edge for negative symptoms or for overall efficacy.

An Answer for Psychotic Depression

February 10, 2020

Randall Moore, MD.

Randall Moore, MD. Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Research tells us how to start meds, but rarely when to stop them. This study brings some needed answers on discontinuing antipsychotics after recovery from psychotic depression.

Steroid-Induced Psychosis in the Pediatric Population

June 11, 2019

Ahhan Nazeer, MD.

Ahhan Nazeer, MD. Dr. Nazeer has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Although childhood psychosis is a rare disorder, an accurate diagnosis is crucial. This article analyzes the results of a 2019 case study of steroid-induced psychosis in a pediatric patient.

Risk of Psychosis With Stimulants in ADHD Patients

June 11, 2019

Pavan Madan, MD

Pavan Madan, MD Dr. Madan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

As of 2007, the FDA requires stimulant manufacturers to warn of possible psychosis with stimulant use. This article analyzes the results of a 2019 study comparing the risk of psychosis between methylphenidate and amphetamine classes of medications.

Evaluating Psychosis in Children

April 24, 2019

Psychosis in children is difficult to determine, especially in younger kids who might not understand the concept of psychotic behavior. In more obvious cases, children will come into your office saying that they are hearing voices, or that someone is chasing them. But how do you evaluate a child for...

How to help your patients quiet their hallucinations

March 21, 2019

How can we help our psychotic patients cope with hallucinations that are still bothering them, despite adequate doses of antipsychotic medication? Here are some techniques to try (acknowledgments to Dr. Dost Ongur of McLean Hospital, who had discussed these in a past issue of The Carlat Psychiatry Report).Music. This sometimes...